Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | COP | XOM |
|---|---|---|
| Price | $129.82 | $162.51 |
| Change today | ▲ 1.35% | ▲ 0.79% |
| Market cap | $155.96B | $668.23B |
| Return, 3 months | +22.2% | +19.5% |
| Return, year to date | +41.7% | +37.8% |
| Return, 1 year | +40.0% | +46.0% |
| P/E (TTM) | 17.2 | 20.9 |
| P/B | 2.4 | 2.6 |
| P/E percentile vs own 5y | 86th | 90th |
| Dividend yield | 2.54% | 2.51% |
| Revenue growth (YoY, latest qtr) | +36.8% | +44.1% |
| Net profit growth (YoY) | +99.4% | +102.4% |
| Gross margin | 27.7% | 20.6% |
| Operating margin | 21.9% | 10.7% |
| Net margin | 14.6% | 9.1% |
| Return on equity | 14.1% | 12.6% |
| Analyst target vs. price | +14.4% | +4.7% |
| Analyst buy share | 84% | 50% |
| RSI (14) | 45 | 51 |
| 30-day volatility | 31.7% | 25.7% |
| Max drawdown, 1 year | -22.3% | -20.1% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.